Get the Stockscreener App
0.00
100.00%
-0.3291
Allakos Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation. Its portfolio consists of antibodies that target receptors, particularly Siglec-6, Siglec-8 and other anti-Siglec antibodies, including some antibodies in preclinical development.
See More
Previous Close:
$0.3291
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$29.69M
Revenue:
-
Net Income/Loss:
$-166.14M
P/E Ratio:
0.00
EPS:
-1.92
Net Cash Flow:
$-139.92M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$1.555
Allakos Inc Stock (ALLK) Company Profile
Name
Allakos Inc
Sector
Industry
Phone
650-597-5002
Address
825 INDUSTRIAL ROAD, SAN CARLOS, CA
Compare ALLK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALLK
Allakos Inc
|
0.00 | 29.69M | 0 | -166.14M | -139.92M | -1.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Allakos Inc Stock (ALLK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-17-24 | Downgrade | Jefferies | Buy → Hold |
| Jan-16-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Dec-18-23 | Upgrade | William Blair | Mkt Perform → Outperform |
| Dec-08-23 | Resumed | Jefferies | Buy |
| Sep-27-23 | Initiated | JMP Securities | Mkt Outperform |
| May-12-23 | Upgrade | Jefferies | Hold → Buy |
| Mar-07-23 | Initiated | Piper Sandler | Overweight |
| Sep-12-22 | Downgrade | SMBC Nikko | Neutral → Underperform |
| Dec-22-21 | Downgrade | BofA Securities | Buy → Underperform |
| Dec-22-21 | Downgrade | Cowen | Outperform → Market Perform |
| Dec-22-21 | Downgrade | Jefferies | Buy → Hold |
| Dec-22-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Dec-22-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Aug-26-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-15-21 | Initiated | Cowen | Outperform |
| May-18-21 | Initiated | H.C. Wainwright | Buy |
| Feb-24-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-15-21 | Initiated | BofA Securities | Buy |
| Dec-21-20 | Initiated | SVB Leerink | Outperform |
| Feb-27-20 | Initiated | Barclays | Underweight |
| Feb-04-20 | Resumed | Goldman | Neutral |
| Aug-13-18 | Initiated | Goldman | Neutral |
| Aug-13-18 | Initiated | Jefferies | Buy |
| Aug-13-18 | Initiated | William Blair | Outperform |
View All
Allakos Inc Stock (ALLK) Latest News
How Resilient Is Allakos Inc. Stock During Economic DownturnsPredictive System for Long-Term Stock Forecast - Newser
Is now a turning point for Allakos Inc.Predictable Income Summary for Long-Term Trades - Newser
What MACD and RSI say about Allakos Inc.Weekly Hot Stocks Based on Volume Flow - Newser
How high can Allakos Inc. stock goLow-Risk Reversal Pattern Analysis Tracker - Newser
What is the dividend policy of Allakos Inc. stockValue Investing Recommendation For Every Investor - jammulinksnews.com
How does Allakos Inc. compare to its industry peersTop Growth Trend Scanner With High Returns - jammulinksnews.com
Should you hold or exit Allakos Inc. nowCapital Secure Pattern Signal Analysis Sheet - Newser
Volume spikes in Allakos Inc. stock – what they meanFree Profit Target Stock Opportunity Monitor - Newser
Detecting price anomalies in Allakos Inc. with AIFree Day Trading Signals With High Precision - Newser
How to interpret RSI for Allakos Inc. stockStrategy Chart for Real-Time Trade Flow - Newser
Quantitative breakdown of Allakos Inc. recent moveTrading Volume Spike and Reversal Analysis - Newser
What institutional investors are buying Allakos Inc. stockStock Strategy Target Finder From AI Tools - jammulinksnews.com
Allakos Inc. Breaks Losing Streak — Is the Trend ReversingHigh Accuracy Alerts for ROI Traders Detected - metal.it
Allakos Inc. Company’s Quarterly Earnings Growth: What the Numbers SayFree AI Driven Stock Trend Forecast - Newser
Trend Reversal Possible in Allakos Inc. Charts IndicateAI Powered High Return Stock Calls Dominate Watchlists - metal.it
What makes Allakos Inc. stock price move sharplyRisk-Managed Strategy Based on Price Analysis - Newser
How strong is Allakos Inc. company’s balance sheetFinancial News Watchlist For 2025 - jammulinksnews.com
How Resilient Is Allakos Inc. Stock During Economic Downturns Entry Zone Watchlist With Momentum Focus - beatles.ru
When is Allakos Inc. stock expected to show significant growthAmplify your gains with low-risk picks - jammulinksnews.com
Is Allakos Inc. stock overvalued or undervaluedMarket-beating returns - jammulinksnews.com
Should I hold or sell Allakos Inc. stock in 2025Explosive wealth accumulation - jammulinksnews.com
What catalysts could drive Allakos Inc. stock higher in 2025Tremendous gains - jammulinksnews.com
Why is Allakos Inc. stock attracting strong analyst attentionBuild a diversified portfolio for maximum returns - jammulinksnews.com
What analysts say about Allakos Inc. stockExceptional market positioning - PrintWeekIndia
Allakos Inc. Stock Analysis and ForecastSuperior stock selection - PrintWeekIndia
Is Allakos Inc. a good long term investmentExtraordinary earning power - Autocar Professional
What drives Allakos Inc. stock priceHigh-octane financial growth - jammulinksnews.com
Allakos Inc Stock (ALLK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):